• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国马里兰州巴尔的摩市急诊科阿片类药物滥用患者使用纳洛酮带回家的途径与障碍

Access and Barriers to Take-Home Naloxone Use among Emergency Department Patients with Opioid Misuse in Baltimore, Maryland, USA.

作者信息

Hurt Brenten R, Hussain Atizaz, Aledhaim Ali, Moayedi Siamak, Schenkel Stephen M, Kim Hong K

机构信息

University of Maryland School of Medicine, Baltimore, MD, USA.

Department of Emergency Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.

出版信息

Subst Use Misuse. 2020;55(13):2237-2242. doi: 10.1080/10826084.2020.1797811. Epub 2020 Jul 30.

DOI:10.1080/10826084.2020.1797811
PMID:32729772
Abstract

The opioid epidemic has prompted the expansion of take-home naloxone (THN) distribution programs. The proportion of emergency department (ED) patients with opioid misuse who have access to a naloxone kit (NK) and barriers to using it are unclear. Characterizing the access and barrier to NK use among at-risk ED patients. We enrolled a convenience sample of ED patients with active opioid misuse from May 21-July 31, 2018. We administered a survey to collect patients' demographic data, substance use history, and access to and use of NK. The primary outcome was NK access (prior receipt of a kit or prescription); secondary outcomes were knowledge and use of NK, and barriers to obtaining and using it. Of 165 respondents, 71.5% knew of THN programs and 57.6% (=95) had access to THN by either having received a NK (=90) or a prescription (=5); 34 respondents received both. Among 39 (23.6%) who received a naloxone prescription, 25 (64.1%) filled it. 60.0% (=99) reported knowing how to administer naloxone; lack of training was the primary reason (=63/66, 96.9%) for their unfamiliarity. Patients who presented after an opioid overdose (25.5%; =42) were less likely to have knowledge of THN programs (57.1% vs. 76.4%), and to have received a NK (35.7% vs. 61.0%). Awareness of THN programs was high among our cohort. But approximately 60% the respondents received a NK or knew how to use it. Despite efforts to expand THN access, gaps in knowledge, access, and use exist.

摘要

阿片类药物流行促使了居家使用纳洛酮(THN)分发项目的扩展。急诊科(ED)中存在阿片类药物滥用问题的患者能够获得纳洛酮试剂盒(NK)的比例以及使用该试剂盒的障碍尚不清楚。本研究旨在描述有风险的急诊科患者获取纳洛酮试剂盒的情况及使用障碍。我们选取了2018年5月21日至7月31日期间急诊科中有阿片类药物滥用行为的患者作为便利样本。我们进行了一项调查,以收集患者的人口统计学数据、物质使用史以及获取和使用纳洛酮试剂盒的情况。主要结局是获取纳洛酮试剂盒(之前收到过试剂盒或处方);次要结局是对纳洛酮试剂盒的知晓和使用情况,以及获取和使用该试剂盒的障碍。在165名受访者中,71.5%知晓THN项目,57.6%(=95人)通过收到纳洛酮试剂盒(=90人)或处方(=5人)获得了THN;34名受访者两者都有。在39名(23.6%)收到纳洛酮处方的患者中,25名(64.1%)取了药。60.0%(=99人)报告知道如何使用纳洛酮;缺乏培训是他们不熟悉使用方法的主要原因(=63/66,96.9%)。在阿片类药物过量服用后前来就诊的患者(25.5%;=42人)知晓THN项目的可能性较小(57.1%对76.4%),且获得纳洛酮试剂盒的可能性也较小(35.7%对61.0%)。我们研究队列中对THN项目的知晓度较高。但约60%的受访者收到过纳洛酮试剂盒或知道如何使用它。尽管努力扩大THN的获取途径,但在知识、获取和使用方面仍存在差距。

相似文献

1
Access and Barriers to Take-Home Naloxone Use among Emergency Department Patients with Opioid Misuse in Baltimore, Maryland, USA.美国马里兰州巴尔的摩市急诊科阿片类药物滥用患者使用纳洛酮带回家的途径与障碍
Subst Use Misuse. 2020;55(13):2237-2242. doi: 10.1080/10826084.2020.1797811. Epub 2020 Jul 30.
2
Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.在繁忙的城市急诊部门,与提供纳洛酮带回家相关的患者特征:回顾性图表审查。
BMC Health Serv Res. 2019 Sep 5;19(1):632. doi: 10.1186/s12913-019-4469-3.
3
Development of a take-home naloxone program at an urban academic emergency department.在城市学术急诊部门开发带教纳洛酮计划。
J Am Pharm Assoc (2003). 2020 Nov-Dec;60(6):e324-e331. doi: 10.1016/j.japh.2020.06.017. Epub 2020 Jul 18.
4
Do electronic health record prompts increase take-home naloxone administration for emergency department patients after an opioid overdose?电子健康记录提示是否会增加急诊科阿片类药物过量患者的纳洛酮带离医嘱?
Addiction. 2019 Sep;114(9):1575-1581. doi: 10.1111/add.14635. Epub 2019 Jun 12.
5
A systematic review of the distribution of take-home naloxone in low- and middle-income countries and barriers to the implementation of take-home naloxone programs.在中低收入国家中,将纳洛酮带回家的分布情况的系统评价以及将纳洛酮带回家方案实施的障碍。
Harm Reduct J. 2022 Oct 20;19(1):117. doi: 10.1186/s12954-022-00700-x.
6
Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with 'take-home naloxone' in emergency departments.在紧急情况下的过量用药和携带纳洛酮回家:一项试点研究,考察在急诊科提供针对预防过量用药的“携带纳洛酮回家”的简短干预措施的可行性。
Emerg Med Australas. 2022 Aug;34(4):509-518. doi: 10.1111/1742-6723.13925. Epub 2022 Jan 12.
7
Yes, not now, or never: an analysis of reasons for refusing or accepting emergency department-based take-home naloxone.是的,不是现在,就是永远:拒绝或接受基于急诊科的纳洛酮带回家方案的原因分析。
CJEM. 2019 Mar;21(2):226-234. doi: 10.1017/cem.2018.368. Epub 2018 May 23.
8
Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a 'moral hazard' associated with naloxone supply.纳洛酮供应是否会导致药物使用增加?一项系统评价评估与纳洛酮供应相关的“道德风险”是否存在证据。
Int J Drug Policy. 2022 Feb;100:103513. doi: 10.1016/j.drugpo.2021.103513. Epub 2021 Nov 16.
9
Opioid education and nasal naloxone rescue kits in the emergency department.急诊科的阿片类药物教育及鼻腔纳洛酮急救包
West J Emerg Med. 2015 May;16(3):381-4. doi: 10.5811/westjem.2015.2.24909. Epub 2015 Apr 1.
10
Rethinking 'carriage' of take-home naloxone.重新思考携带纳洛酮回家。
Int J Drug Policy. 2021 Sep;95:103253. doi: 10.1016/j.drugpo.2021.103253. Epub 2021 Apr 11.

引用本文的文献

1
Harm reduction strategies in acute care for people who use alcohol and/or drugs: A scoping review.急性医疗中针对使用酒精和/或药物的人群的减少伤害策略:范围综述。
PLoS One. 2023 Dec 15;18(12):e0294804. doi: 10.1371/journal.pone.0294804. eCollection 2023.
2
A pilot study of a mixed-method approach to design an ED-based peer mHealth referral tool for HIV/HCV and opioid overdose prevention services.一项混合方法设计 ED 为基础的同伴移动医疗转介工具的初步研究,用于预防 HIV/HCV 和阿片类药物过量。
Drug Alcohol Depend. 2022 Sep 1;238:109585. doi: 10.1016/j.drugalcdep.2022.109585. Epub 2022 Jul 23.